The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Solid Tumor Drug Market Research Report 2025
Synopsis
The global Solid Tumor Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Solid Tumor Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Drug.
Report Scope
The Solid Tumor Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid Tumor Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Tumor Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
Segment by Type
Small Molecules
Biologics
Segment by Application
Oncology
Neurology
Radiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Tumor Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Solid Tumor Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Solid Tumor Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Drug.
Report Scope
The Solid Tumor Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid Tumor Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Tumor Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
Segment by Type
Small Molecules
Biologics
Segment by Application
Oncology
Neurology
Radiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Tumor Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Solid Tumor Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Radiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Tumor Drug Market Perspective (2019-2030)
2.2 Solid Tumor Drug Growth Trends by Region
2.2.1 Global Solid Tumor Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Solid Tumor Drug Historic Market Size by Region (2019-2024)
2.2.3 Solid Tumor Drug Forecasted Market Size by Region (2025-2030)
2.3 Solid Tumor Drug Market Dynamics
2.3.1 Solid Tumor Drug Industry Trends
2.3.2 Solid Tumor Drug Market Drivers
2.3.3 Solid Tumor Drug Market Challenges
2.3.4 Solid Tumor Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Tumor Drug Players by Revenue
3.1.1 Global Top Solid Tumor Drug Players by Revenue (2019-2024)
3.1.2 Global Solid Tumor Drug Revenue Market Share by Players (2019-2024)
3.2 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid Tumor Drug Revenue
3.4 Global Solid Tumor Drug Market Concentration Ratio
3.4.1 Global Solid Tumor Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2023
3.5 Solid Tumor Drug Key Players Head office and Area Served
3.6 Key Players Solid Tumor Drug Product Solution and Service
3.7 Date of Enter into Solid Tumor Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid Tumor Drug Breakdown Data by Type
4.1 Global Solid Tumor Drug Historic Market Size by Type (2019-2024)
4.2 Global Solid Tumor Drug Forecasted Market Size by Type (2025-2030)
5 Solid Tumor Drug Breakdown Data by Application
5.1 Global Solid Tumor Drug Historic Market Size by Application (2019-2024)
5.2 Global Solid Tumor Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Solid Tumor Drug Market Size (2019-2030)
6.2 North America Solid Tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Solid Tumor Drug Market Size by Country (2019-2024)
6.4 North America Solid Tumor Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Tumor Drug Market Size (2019-2030)
7.2 Europe Solid Tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Solid Tumor Drug Market Size by Country (2019-2024)
7.4 Europe Solid Tumor Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid Tumor Drug Market Size (2019-2030)
8.2 Asia-Pacific Solid Tumor Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Solid Tumor Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Solid Tumor Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid Tumor Drug Market Size (2019-2030)
9.2 Latin America Solid Tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Solid Tumor Drug Market Size by Country (2019-2024)
9.4 Latin America Solid Tumor Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Tumor Drug Market Size (2019-2030)
10.2 Middle East & Africa Solid Tumor Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Solid Tumor Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Solid Tumor Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Solid Tumor Drug Introduction
11.1.4 AstraZeneca Revenue in Solid Tumor Drug Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen Solid Tumor Drug Introduction
11.2.4 Biogen Revenue in Solid Tumor Drug Business (2019-2024)
11.2.5 Biogen Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Solid Tumor Drug Introduction
11.3.4 Baxter Revenue in Solid Tumor Drug Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Detail
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Solid Tumor Drug Introduction
11.4.4 Celgene Corporation Revenue in Solid Tumor Drug Business (2019-2024)
11.4.5 Celgene Corporation Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Solid Tumor Drug Introduction
11.5.4 Abbott Laboratories Revenue in Solid Tumor Drug Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Detail
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Solid Tumor Drug Introduction
11.6.4 Pfizer Inc Revenue in Solid Tumor Drug Business (2019-2024)
11.6.5 Pfizer Inc Recent Development
11.7 Amgen Limited & Amgen Ireland Limited
11.7.1 Amgen Limited & Amgen Ireland Limited Company Detail
11.7.2 Amgen Limited & Amgen Ireland Limited Business Overview
11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Introduction
11.7.4 Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2019-2024)
11.7.5 Amgen Limited & Amgen Ireland Limited Recent Development
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Detail
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2019-2024)
11.8.5 Bristol-Myers Squibb Company Recent Development
11.9 GlaxoSmithKline plc.
11.9.1 GlaxoSmithKline plc. Company Detail
11.9.2 GlaxoSmithKline plc. Business Overview
11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Introduction
11.9.4 GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2019-2024)
11.9.5 GlaxoSmithKline plc. Recent Development
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Detail
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2019-2024)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Detail
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Solid Tumor Drug Introduction
11.11.4 Eli Lilly and Company Revenue in Solid Tumor Drug Business (2019-2024)
11.11.5 Eli Lilly and Company Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Detail
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Solid Tumor Drug Introduction
11.12.4 Johnson & Johnson Revenue in Solid Tumor Drug Business (2019-2024)
11.12.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Solid Tumor Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global Solid Tumor Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Solid Tumor Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Solid Tumor Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Solid Tumor Drug Market Share by Region (2019-2024)
Table 8. Global Solid Tumor Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Solid Tumor Drug Market Share by Region (2025-2030)
Table 10. Solid Tumor Drug Market Trends
Table 11. Solid Tumor Drug Market Drivers
Table 12. Solid Tumor Drug Market Challenges
Table 13. Solid Tumor Drug Market Restraints
Table 14. Global Solid Tumor Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Solid Tumor Drug Market Share by Players (2019-2024)
Table 16. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2023)
Table 17. Ranking of Global Top Solid Tumor Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Solid Tumor Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Solid Tumor Drug Product Solution and Service
Table 21. Date of Enter into Solid Tumor Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Solid Tumor Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Solid Tumor Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Solid Tumor Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Solid Tumor Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Solid Tumor Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Solid Tumor Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Solid Tumor Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Solid Tumor Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Solid Tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Solid Tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Solid Tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Solid Tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Solid Tumor Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Solid Tumor Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Solid Tumor Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Solid Tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Solid Tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Solid Tumor Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Solid Tumor Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. AstraZeneca Company Detail
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Solid Tumor Drug Product
Table 49. AstraZeneca Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. Biogen Company Detail
Table 52. Biogen Business Overview
Table 53. Biogen Solid Tumor Drug Product
Table 54. Biogen Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 55. Biogen Recent Development
Table 56. Baxter Company Detail
Table 57. Baxter Business Overview
Table 58. Baxter Solid Tumor Drug Product
Table 59. Baxter Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 60. Baxter Recent Development
Table 61. Celgene Corporation Company Detail
Table 62. Celgene Corporation Business Overview
Table 63. Celgene Corporation Solid Tumor Drug Product
Table 64. Celgene Corporation Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 65. Celgene Corporation Recent Development
Table 66. Abbott Laboratories Company Detail
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Solid Tumor Drug Product
Table 69. Abbott Laboratories Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Pfizer Inc Company Detail
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Solid Tumor Drug Product
Table 74. Pfizer Inc Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Amgen Limited & Amgen Ireland Limited Company Detail
Table 77. Amgen Limited & Amgen Ireland Limited Business Overview
Table 78. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product
Table 79. Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 80. Amgen Limited & Amgen Ireland Limited Recent Development
Table 81. Bristol-Myers Squibb Company Company Detail
Table 82. Bristol-Myers Squibb Company Business Overview
Table 83. Bristol-Myers Squibb Company Solid Tumor Drug Product
Table 84. Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 85. Bristol-Myers Squibb Company Recent Development
Table 86. GlaxoSmithKline plc. Company Detail
Table 87. GlaxoSmithKline plc. Business Overview
Table 88. GlaxoSmithKline plc. Solid Tumor Drug Product
Table 89. GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 90. GlaxoSmithKline plc. Recent Development
Table 91. F. Hoffmann-La Roche Ltd. Company Detail
Table 92. F. Hoffmann-La Roche Ltd. Business Overview
Table 93. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product
Table 94. F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 95. F. Hoffmann-La Roche Ltd. Recent Development
Table 96. Eli Lilly and Company Company Detail
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Solid Tumor Drug Product
Table 99. Eli Lilly and Company Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 100. Eli Lilly and Company Recent Development
Table 101. Johnson & Johnson Company Detail
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Solid Tumor Drug Product
Table 104. Johnson & Johnson Revenue in Solid Tumor Drug Business (2019-2024) & (US$ Million)
Table 105. Johnson & Johnson Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Tumor Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Solid Tumor Drug Market Share by Type: 2023 VS 2030
Figure 3. Small Molecules Features
Figure 4. Biologics Features
Figure 5. Global Solid Tumor Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Solid Tumor Drug Market Share by Application: 2023 VS 2030
Figure 7. Oncology Case Studies
Figure 8. Neurology Case Studies
Figure 9. Radiology Case Studies
Figure 10. Others Case Studies
Figure 11. Solid Tumor Drug Report Years Considered
Figure 12. Global Solid Tumor Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Solid Tumor Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Solid Tumor Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Solid Tumor Drug Market Share by Players in 2023
Figure 16. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Solid Tumor Drug Revenue in 2023
Figure 18. North America Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Solid Tumor Drug Market Share by Country (2019-2030)
Figure 20. United States Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Solid Tumor Drug Market Share by Country (2019-2030)
Figure 24. Germany Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Solid Tumor Drug Market Share by Region (2019-2030)
Figure 32. China Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Solid Tumor Drug Market Share by Country (2019-2030)
Figure 40. Mexico Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Solid Tumor Drug Market Share by Country (2019-2030)
Figure 44. Turkey Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Solid Tumor Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 47. Biogen Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 48. Baxter Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 49. Celgene Corporation Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 50. Abbott Laboratories Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 51. Pfizer Inc Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 52. Amgen Limited & Amgen Ireland Limited Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 54. GlaxoSmithKline plc. Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 55. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 57. Johnson & Johnson Revenue Growth Rate in Solid Tumor Drug Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
